Found 4 matching trials
Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1
PHASE2The immunogenicity and safety profiles of AdCLD-CoV19-1 (5.0ร10\^10 VP/dose...
Location
Korea University Ansan Hospital
Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers
PHASE3The immunogenicity and safety of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/...
Status
Active Not Recruiting
Location
The Medical City-Iloilo
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
PHASE1This is a Phase 1 clinical trial to assess the safety and immunogenicity of...
Location
Korea University Ansan Hospital
Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine
PHASE1The safety and immunogenicity of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/...
Location
Hallym University Dongtan Sacred Heart Hospital